接种COVID-19疫苗后的小纤维神经病变:一个病例系列
Giulia Carolina Primicerio1, Margrethe B Bille1, Eva Løbner Lund2
1Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
Journal of the neurological sciences
|May 15, 2025
概括
在COVID-19疫苗接种后的小纤维神经病变 (SFN) 正在调查中. 这项研究分析了16名患者,发现了潜在的联系,并支持对罕见疫苗副作用的营销后监测.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 周围神经病变是已知的疫苗副作用.
- 小纤维神经病变 (SFN) 和疫苗接种之间的联系仍然不清楚.
- 由于随访时间有限,评估COVID-19疫苗接种后的SFN因果关系具有挑战性.
研究的目的:
- 调查COVID-19疫苗接种后疑似SFN的患者的临床和电生理学特征.
- 探索COVID-19疫苗接种和SFN开发之间的潜在关联.
- 强调营销后监测对于识别罕见不良事件的重要性.
主要方法:
- 临床和电生理学数据的回顾性分析.
- 包括16名疑似SFN疫苗接种后患者.
- 根据既定标准对SFN进行诊断.
主要成果:
- 16名患者中有9人符合SFN的诊断标准.
- 收集和描述了临床和电生理学数据.
- 时间性和与其他条件的类比表明可能存在联系.
结论:
- 这些发现表明,COVID-19疫苗接种和SFN之间存在潜在的关联.
- 对病理生理学的进一步研究是有必要的.
- 营销后监测对于检测和管理罕见的疫苗相关不良反应至关重要.
相关概念视频
Local Anesthetics: Differential Sensitivity of Nerve Fibers
795
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
795
Myasthenia Gravis: Diagnostic Tests
705
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Allergic Drug Reactions
821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
Local Anesthetics: Adverse Effects
399
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
399
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K


